July 29, 2009

BioSyntech Announces Year End and Fourth Quarter Fiscal 2009 Financial Results and Management Changes

LAVAL, Quebec — June 29, 2009 — BioSyntech, Inc. (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced its financial and operational results for the fiscal year, ending March 31, 2009.   More

June 17, 2009

BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel® Cartilage Repair Device

LAVAL, Quebec — June 17, 2009 — BioSyntech, Inc. (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced statistically significant results from an analysis of patients who completed their 12 month follow-up in the BST-CarGel® randomized clinical trial.   More

June 11, 2009

BioSyntech Gives Notice to Debentureholders and Announces Resignation of Board Member

LAVAL, Quebec — June 11, 2009 — BioSyntech, Inc. (TSX: BSY) (the Company) gave notice to its debentureholders that it exercised its right to make the interest payment of $745,800 due on June 30, 2009 by issuing common shares. The number of common shares to be issued on June 30, 2009 will be equal to the amount of the interests, divided by 95% of the volume weighted average trading price per common share for the five trading days immediately preceding.   More